Experience
Avid Bioservices Announces $1.1 Billion Acquisition by GHO Capital Partners and Ampersand Capital Partners
November 6, 2024
Cooley advised Avid Bioservices (Nasdaq: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, on its definitive merger agreement to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion.
Related contacts
Related Practices & Industries
Veritone Announces Sale of Veritone One to Insignia for up to $104 Million
October 22, 2024
Cooley advised Veritone, a company building human-centered enterprise artificial intelligence (AI) solutions, on the sale of its media agency, Veritone One, to Insignia Capital Group.
Related contacts
Related Practices & Industries
RTZ Systems Announces Acquisition by CollabriOS Health
October 10, 2024
Cooley advised RTZ Systems, an information technology and services company, on its acquisition by CollabriOS Health, a new entity formed by Assured Healthcare Partners that brings together a suite of integrated technology infrastructure, including electronic health records, third-party administrator financial services, and care coordination solutions designed to help Programs of All-Inclusive Care for the Elderly (PACE) optimize workflows, streamline business processes and enhance overall center operations.
Related contacts
Cannae Holdings and KDSA Announce Majority Stake Acquisition in The Watkins Company
October 7, 2024
Cooley advised Cannae Holdings (NYSE: CNNE), an investment firm with stakes in restaurants, technology-enabled healthcare services, financial services and more, on its partnership with KDSA Investment Partners to acquire a majority stake in The Watkins Company, a 156-year-old American heritage brand renowned for its high-quality flavoring products.
Related contacts
Related Practices & Industries
PetIQ Announces Definitive Merger Agreement With Bansk Group Valued at Approximately $1.5 Billion
August 7, 2024
Cooley advised PetIQ (Nasdaq: PETQ), a leading pet medication, health and wellness company, on its definitive merger agreement with Bansk Group, pursuant to which Bansk Group will acquire all outstanding shares of PetIQ’s common stock for $31 per share in an all-cash transaction valued at approximately $1.5 billion.
Related contacts
Related Practices & Industries
Related news and events
Avid Bioservices Announces $1.1 Billion Acquisition by GHO Capital Partners and Ampersand Capital Partners
Veritone Announces Sale of Veritone One to Insignia for up to $104 Million
Admissions and credentials
New York